Citations (18)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (1)
Zhen-Jie Wu, Jia-Chang Tan, Xiong Qin, Bin Liu & Zhen-Chao Yuan. (2018) Significance of circulating tumor cells in osteosarcoma patients treated by neoadjuvant chemotherapy and surgery. Cancer Management and Research 10, pages 3333-3339.
Read now
Read now
Articles from other publishers (17)
Shuangwu Dai, Xinxin Shao, Qingzhu Wei, Shaohua Du, Changhe Hou, Haomiao Li & Dadi Jin. (2023) Association of circulating tumor cells and IMP3 expression with metastasis of osteosarcoma. Frontiers in Oncology 13.
Crossref
Crossref
Hye Min Ju, Byung-Chul Kim, Ilhan Lim, Byung Hyun Byun & Sang-Keun Woo. (2023) Estimation of an Image Biomarker for Distant Recurrence Prediction in NSCLC Using Proliferation-Related Genes. International Journal of Molecular Sciences 24:3, pages 2794.
Crossref
Crossref
Nutnicha Sirikaew, Dumnoensun Pruksakorn, Parunya Chaiyawat & Somchai Chutipongtanate. (2022) Mass Spectrometric-Based Proteomics for Biomarker Discovery in Osteosarcoma: Current Status and Future Direction. International Journal of Molecular Sciences 23:17, pages 9741.
Crossref
Crossref
Ganesh Kumar Barik, Osheen Sahay, Debasish Paul & Manas Kumar Santra. (2022) Ezrin gone rogue in cancer progression and metastasis: An enticing therapeutic target. Biochimica et Biophysica Acta (BBA) - Reviews on Cancer 1877:4, pages 188753.
Crossref
Crossref
Pattaralawan Sittiju, Parunya Chaiyawat, Dumnoensun Pruksakorn, Jeerawan Klangjorhor, Weerinrada Wongrin, Phichayut Phinyo, Rawikant Kamolphiwong, Areerak Phanphaisarn, Pimpisa Teeyakasem, Prachya Kongtawelert & Peraphan Pothacharoen. (2022) Osteosarcoma-Specific Genes as a Diagnostic Tool and Clinical Predictor of Tumor Progression. Biology 11:5, pages 698.
Crossref
Crossref
Fei Fei, Shuko Harada, Shi Wei & Gene P. Siegal. 2022. Bone Cancer. Bone Cancer
579
590
.
Marta Téllez-Gabriel & Dominique Heymann. 2022. Bone Cancer. Bone Cancer
487
500
.
Argyris C. Hadjimichael, Alexandros Pergaris, Angelos Kaspiris, Athanasios F. Foukas & Stamatios E. Theocharis. (2021) Liquid Biopsy: A New Translational Diagnostic and Monitoring Tool for Musculoskeletal Tumors. International Journal of Molecular Sciences 22:21, pages 11526.
Crossref
Crossref
Zahra Sadat Razavi, Vida Tajiknia, Shahab Majidi, Maryam Ghandali, Hamid Reza Mirzaei, Neda Rahimian, Michael R. Hamblin & Hamed Mirzaei. (2021) Gynecologic cancers and non-coding RNAs: Epigenetic regulators with emerging roles. Critical Reviews in Oncology/Hematology 157, pages 103192.
Crossref
Crossref
Danfei Xu, Fengzhi Feng, Yuqing Pei, Yujuan Zhang, Yue Wu, Yi Guo & Wei Cui. (2020) Differential expression of SALL4 in CTCs derived from hydatidiform moles and gestational trophoblastic neoplasms. American Journal of Reproductive Immunology 83:5.
Crossref
Crossref
Miguel Pereira-Silva, Carmen Alvarez-Lorenzo, Angel Concheiro, Ana Cláudia Santos, Francisco Veiga & Ana Figueiras. (2020) Nanomedicine in osteosarcoma therapy: Micelleplexes for delivery of nucleic acids and drugs toward osteosarcoma-targeted therapies. European Journal of Pharmaceutics and Biopharmaceutics 148, pages 88-106.
Crossref
Crossref
Minghui Li, Yajie Lu, Zuoyao Long, Mengyang Li, Jing Kong, Guojing Chen & Zhen Wang. (2019) Prognostic and clinicopathological significance of circulating tumor cells in osteosarcoma. Journal of Bone Oncology 16, pages 100236.
Crossref
Crossref
Ferdinand Wagner, Boris M. Holzapfel, Laure C. Martine, Jacqui McGovern, Christoph A. Lahr, Melanie Boxberg, Peter M. Prodinger, Susanne Grässel, Daniela Loessner & Dietmar W. Hutmacher. (2019) A humanized bone microenvironment uncovers HIF2 alpha as a latent marker for osteosarcoma. Acta Biomaterialia 89, pages 372-381.
Crossref
Crossref
Radoslav Zamborsky, Milan Kokavec, Stefan Harsanyi & Lubos Danisovic. (2019) Identification of Prognostic and Predictive Osteosarcoma Biomarkers. Medical Sciences 7:2, pages 28.
Crossref
Crossref
Hua Yan, Bing‑Mei Sun, Yu‑Ying Zhang, Yu‑Juan Li, Cheng‑Xiang Huang, Fu‑Zhong Feng & Cui Li. (2018) Upregulation of miR-183-5p is responsible for the promotion of apoptosis and inhibition of the epithelial-mesenchymal transition, proliferation, invasion and migration of human endometrial cancer cells by downregulating Ezrin. International Journal of Molecular Medicine.
Crossref
Crossref
Ferdinand Wagner, Boris M. Holzapfel, Jacqui A. McGovern, Abbas Shafiee, Jeremy G. Baldwin, Laure C. Martine, Christoph A. Lahr, Felix M. Wunner, Thor Friis, Onur Bas, Melanie Boxberg, Peter M. Prodinger, Ali Shokoohmand, Davide Moi, Roberta Mazzieri, Daniela Loessner & Dietmar W. Hutmacher. (2018) Humanization of bone and bone marrow in an orthotopic site reveals new potential therapeutic targets in osteosarcoma. Biomaterials 171, pages 230-246.
Crossref
Crossref
Lavinia Raimondi, Angela De Luca, Viviana Costa, Nicola Amodio, Valeria Carina, Daniele Bellavia, Pierfrancesco Tassone, Stefania Pagani, Milena Fini, Riccardo Alessandro & Gianluca Giavaresi. (2017) Circulating biomarkers in osteosarcoma: new translational tools for diagnosis and treatment. Oncotarget 8:59, pages 100831-100851.
Crossref
Crossref